CXCR1 and breast cancer: In view of the role of IL-8 in mediating BCSC self-renewal and breast cancer chemoresistance, several IL-8 releasing inhibitors, small-molecule CXCR1/2 inhibitors and neutralizing antibodies against IL-8 and CXCR1/2 have been reported during the past two decades [68].